Four DCB professorships advance research in diabetes technology

The Diabetes Center Berne (DCB) is proud of the joint achievements of its four professors — Prof. Dr. Lilian Witthauer, Prof. Dr. Lisa Koch, Prof. Dr. Maria Louisa Balmer and Prof. Dr. José Garcia — and their teams. Together, the four professorships have built a highly productive research environment in recent years, driving innovation in diabetes technology and strengthening the international visibility of this field. 

In 2025, the four DCB professorships jointly published or contributed to 32 scientific publications. These outputs reflect steadily growing scientific activity across the research portfolio and underline the relevance and quality of the work conducted within the DCB ecosystem. 

In addition to publications, the teams delivered 37 contributions at national and international scientific conferences. These presentations play an important role in fostering exchange with the international research community, clinical partners and industry stakeholders in the field of diabetes technology. 

The teams have also been successful in securing research funding: in recent years, the professorships have jointly raised more than CHF 6 million from competitive funding programmes, foundations and industry-supported research collaborations. These resources enable the development, validation and gradual translation of new technologies towards real-world application. 

At the same time, the scientific environment around the four professorships has continued to grow. Today, a total of 61 researchers work across the DCB professorships, reflecting the dynamic development of the centre. The teams bring together expertise in science, engineering, clinical research and data science, creating an interdisciplinary environment for developing new solutions in diabetes care. 

The Diabetes Center Berne is proud to provide a platform for this network of researchers. Through close collaboration between science, clinical practice and industry partners, the centre contributes to accelerating technological innovation and improving the lives of people living with diabetes.